Open original FDA record ↗Recall record
- FDA identifier
- Z-2201-2026
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- May 14, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Software issue: When programming the SynchroMed Pump with the A810 CP App in Flex Infusion Mode, the infusion steps should automatically be arranged in consecutive order, from earliest to latest. However, in rare cases, the steps may be displayed out of order. If this occurs, the programmed Flex Infusion schedule will not be delivered at the intended time, if at all.
Source facts
- Action
- Medtronic issued an URGENT: MEDICAL DEVICE CORRECTION notice to its consignees on 4/8/2026 via email and mail. The notice explained the issue with the device and provided the following: "Recommendations: Review the order of Flex Infusion steps for patients previously programmed in Flex Infusion Mode: Review the Session Report from the prior interrogation. Access the report via the A810 application by communicating with the pump, then navigating to Settings > Reports > Session Long Report, and review the patient s previous programming session. Within Current Settings, confirm that the steps and durations are listed in the correct chronological order. If steps are not in chronological time order, either change the timing of the steps so they appear in order or reprogram while adding steps in chronological time order. When programming in Flex Infusion mode: Program Flex Infusion steps in chronological order. Before completing programming, confirm on the Finish screen that all steps appear in chronological time order (earliest to latest). If steps are not in chronological time order, reorder. Actions: Share this notice with all those who need to be aware of this issue within your organization and maintain a copy of this notice in your records. Please complete and return the Customer Confirmation Form enclosed with this letter, acknowledging that you have received this information. The form may be emailed to neuro.quality@medtronic.com." For questions regarding this communication, please contact Medtronic Technical Services at 1-800-707-0933 or your local Medtronic representative.
- Initiated
- 2026-04-08
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution.
- Recall number
- Z-2201-2026
- Recall status
- Open, Classified
- CDRH record ID
- 219693
- FDA classified
- 2026-05-14
- Recall event number
- 98750